
1. Short title
This Act may be cited as the Allergen Disclosure In Non-food Articles Act or the ADINA Act.  2. Labeling of drugs with an ingredient that is a major food allergen or is made from a gluten-containing grain
 (a) Misbranding
Section 502 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 352) is amended by adding at the end the following:

(hh) If it is a drug— 
(1) that is intended for human use;

(2) that contains an ingredient that is, or is derived directly or indirectly from— (A) a major food allergen; or
(B) a gluten-containing grain (including wheat, barley, rye, and their crossbred hybrids); and 
(3) whose label fails—
(A) to state that the drug contains such an ingredient; and (B) to identify each such ingredient and, as applicable, the type of gluten-containing grain..
(b) Applicability
Section 502(hh) of the Federal Food, Drug, and Cosmetic Act, as added by subsection (a), shall apply beginning on the earlier of— 
(1) a date to be determined by the Secretary of Health and Human Services; or

(2) the date that is 2 years after the date of the enactment of this Act. 